tert-Butyl 8-(Hydroxymethyl)-2-oxa-6-azaspiro[3.4]octane-6-carboxylate

Catalog No. :
ACYDOS162
CAS No. :
1934949-83-3
Molecular Formula :
C12H21NO4
Molecular Weight :
243.30

IUPAC Name:tert-butyl 8-(hydroxymethyl)-2-oxa-6-azaspiro[3.4]octane-6-carboxylate

tert-Butyl 8-(Hydroxymethyl)-2-oxa-6-azaspiro[3.4]octane-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$457.00Login to see priceInquiryInquiry
250mg95%$731.00Login to see priceInquiryInquiry
500mg95%$1215.00Login to see priceInquiryInquiry
1g95%$1823.00Login to see priceInquiryInquiry
5g95%$5467.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 8-(Hydroxymethyl)-2-oxa-6-azaspiro[3.4]octane-6-carboxylate
IUPAC Nametert-butyl 8-(hydroxymethyl)-2-oxa-6-azaspiro[3.4]octane-6-carboxylate
MDL No.MFCD30829958
Molecular FormulaC12H21NO4
Molecular Weight243.30
SMILESO=C(OC(C)(C)C)N(CC12COC2)CC1CO
InChI KeyTWKQLQCOGICAGX-UHFFFAOYSA-N
Synonym2-Oxa-6-azaspiro[3.4]octane-6-carboxylic acid, 8-(hydroxymethyl)-, 1,1-dimethylethyl ester;tert-butyl 5-(hydroxymethyl)-2-oxa-7-azaspiro[3.4]octane-7-carboxylate
CAS No.1934949-83-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYDOS162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYDOS162 route product structure diagram
    ACYDOS1621934949-83-3
Inquiry

2. ACYDOS162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYDOS162 route product structure diagram
    ACYDOS1621934949-83-3
Inquiry

Comments (0)